Quantcast
Skip to main content
Department of Neurological Surgery

Department of Neurological Surgery

Spine Center Research

Actively enrolling and upcoming studies

 

Sponsor Title Site Eligibility

PI/Co-PI
Sub-Investigators

Globus, Inc Does the type of procedure affect the incidence of dysphagia and dysphonia in ACDF patients? Cervical

One level ACDF

Radomized Trial of Globus Coalition vs Colonial + Providence using Autogenious Bone Material

Kim
Klineberg, Roberto

Mesoblast MSB-CF002 Multi-level ACDF using NeoFuse with MasterGraft. Phase 1b/2a Cervical

Two or three level ACDF

Randomized Trial of NeoFuse (MPC's) plus Mastergraft Matrix vs cervical allograft spacer control

Kim/Klineberg
Roberto

 Mesoblast MSB-DR003 Lumbar Disc Rengeration Study  Lumbar 

Chronic low back pain > 6 months due to DDD at one level L1 to S1 and failed three months of conservative therapy

Randomized trial of single injetion of MPC's (high dos vs low dose) combined with hyaluronic acid (HA) vs. control injection (HA vs. saline) into symptomatic disc 

Kim/Scott Fishman
Klineberg, Roberto 

Lanx, Inc. Randomized study of ASPEN (R) Spinous Process System vs Pedicle screws in ALIF  Lumbar 

One level ALIF with posterior fixation

Randomized Trial of Aspen vs Pedicle screws 

Kim
Klineberg 

AOSpine Efficacy of Riluzole in Patient with Cerical Spondylotic Myelopathy Undergoing Surgical Treatment   Cervical

Cervical myelopathy undergoing surgical decompression

Randomized trial of Riluzole, 50 mg bid vs placebo 14 days prior to surgery through 28 days postop.

Kim/Klinesberg
Roberto, Gupta 

Covidien DuraSeal Exact Spine Sealant Post-Approval Study  Dural openings 

Planned or incidental dural openings

Prospective: planned or incidental use of DuraSeal Exact during surgery
Retrospective: any method other than DuraSeal Exact used for planned or inciental dural opening. Surgery occured < 24 mo from study initiation visits.

Kim/Boggan
Gupta 

 Asubio-SUN SUN13837 Injection for acute spinal cord injury  Cervical 

Closed single traumatic SCI between C4 through C7. Must receive first dose of druge within 12 hours of injury.

Randomized trial of SUN13837 injection vs placebo x 28 days. 

Kim/Klineberg
Roberto, Gupta 

 

Updated October 2012